Mutenko H, Makitrinskyy R, Tsypik O, Walker S, Ostash B, Fedorenko V
Ivan Franko National University of Lviv, Department of Genetics and Biotechnology, Hrushevskoho st. 4, Lviv 79005, Ukraine.
Harvard Medical School, Department of Microbiology and Immunobiology, 4 Blackfan street, Boston, MA 02115, USA.
Russ J Genet. 2014 Jun;50(6):563-568. doi: 10.1134/S1022795414060076.
Moenomycins (Mm) - phosphoglycolipid compounds produced by ATCC14672 - are considered a promising model for development of novel class of antibiotics. In this regard it is important to generate Mm overproducing strains which would be a basis for economically justified production of this antibiotic. In this work a set of genes for synthesis and reception of low-molecular weight signaling molecules (LSM) in ATCC14672 were described and their significance for Mm production was studied. The ATCC14672 genome carries structural and regulatory genes for production of LSMs of avenolide and γ-butyrolactone families. Additional copies of LSM biosynthetic genes and did not alter the Mm production level. ATCC14672 LSMs are not capable of restoring the sporulation of butyrolactone-nonproducing mutant of . Likewise, while the heterologous host 1326 produced Mm, its mutant M707 (deficient in the butyrolactone synthase gene ) did not. Thus, while the natural level of LSMs production by ATCC14672 does not limit Mm synthesis, the former is essential for the synthesis of moenomycins.
莫能霉素(Mm)——由ATCC14672产生的磷酸糖脂化合物——被认为是开发新型抗生素的一个有前景的模型。在这方面,培育莫能霉素高产菌株很重要,这将是该抗生素经济可行生产的基础。在这项工作中,描述了ATCC14672中一组用于合成和接收低分子量信号分子(LSM)的基因,并研究了它们对莫能霉素生产的重要性。ATCC14672基因组携带用于生产燕麦内酯和γ-丁内酯家族LSM的结构和调控基因。LSM生物合成基因的额外拷贝并没有改变莫能霉素的生产水平。ATCC14672的LSM不能恢复不产生丁内酯的突变体的孢子形成。同样,虽然异源宿主1326能产生莫能霉素,但其突变体M707(丁内酯合酶基因缺陷)则不能。因此,虽然ATCC14672产生LSM的天然水平并不限制莫能霉素的合成,但前者对莫能霉素的合成至关重要。